Strides Pharma recognized in S&P Global Sustainability Yearbook 2025

New Delhi: Strides Pharma Science Limited has been recognized in the S&P Global Sustainability Yearbook 2025, placing it among the top 10 percent of companies globally.

The recognition highlights the company’s Environmental, Social, and Governance (ESG) performance and commitment to sustainability.

The S&P Global Sustainability Yearbook assesses companies across various industries based on ESG performance. For the 2025 edition, 7,690 companies across more than 60 industries were evaluated, with 780 making it into the Yearbook. Within the pharmaceutical and biotechnology sector, 35 companies were included globally, with 16 in the top 10 percent. In India, 51 companies were recognized, including five pharmaceutical and biotechnology firms achieving top 5 or 10 percent placement.

Strides demonstrated strong performance across ESG dimensions. In Environmental Stewardship, the company ranked in the 87^thpercentile, with waste management practices placing it in the 99^th percentile for Waste and Pollutants. It also achieved a 94^th percentile ranking in Energy Management and Environmental Policy and Management. In Social Responsibility, Strides ranked in the 97^th percentile, with a 100^th percentile ranking in Customer Relations and high rankings in Human Capital Management (96^th percentile) and Contribution to Societal Healthcare (95^th percentile).

The company also ranked in the 94^th percentile for Business Ethics, supported by strong performance in Policy Influence and Crisis Management.